Illumina, Inc. vs BlackRock TCP Capital Corp — how do they compare? Illumina, Inc. trades at $192.8 (market cap $27.94B), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: Illumina, Inc. is far larger — about 103.4× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays a 26.09% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | TCPC | |
|---|---|---|
Market Cap | $27.94B | $270.17M |
Sector | Health | Financials |
52-Week High | $194.33 | $7.64 |
52-Week Low | $91.00 | $3.14 |
Enterprise Value | $29.33B | — |
Dividend Yield | — | 26.09% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →